Wolverine Trading, LLC Catalyst Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$13.18 - $17.11 $233,286 - $302,847	17,700 New	17,700 $282,000
Q3 2023 Nov 15, 2023	BUY	$11.69 - $15.02 $63,126 - $81,108	5,400 Added 49.54%	16,300 $190,000
Q2 2023 Aug 23, 2023	SELL	$11.5 - $18.08 $213,900 - $336,287	-18,600 Reduced 63.05%	10,900 $146,000
Q1 2023 May 15, 2023	SELL	$14.34 - $21.05 $104,682 - $153,665	-7,300 Reduced 19.84%	29,500 $486,000
Q4 2022 Feb 14, 2023	BUY	$12.25 - $19.5 $268,275 - $427,050	21,900 Added 146.98%	36,800 $684,000
Q3 2022 Nov 14, 2022	SELL	$7.06 - $15.52 $13,414 - $29,488	-1,900 Reduced 11.31%	14,900 $189,000
Q2 2022 Aug 15, 2022	BUY	$6.23 - $8.57 $104,664 - $143,976	16,800 New	16,800 $117,000
Q2 2021 Aug 06, 2021	SELL	$4.29 - $6.05 $108,966 - $153,670	-25,400 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$3.45 - $4.69 $45,885 - $62,377	13,300 Added 109.92%	25,400 $110,000
Q4 2020 Feb 12, 2021	SELL	$2.97 - $3.83 $6,237 - $8,043	-2,100 Reduced 14.79%	12,100 $41,000
Q3 2020 Nov 13, 2020	BUY	$2.97 - $5.08 $42,174 - $72,136	14,200 New	14,200 $46,000
Q2 2020 Aug 13, 2020	SELL	$3.48 - $5.05 $86,304 - $125,240	-24,800 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$2.61 - $5.21 $14,877 - $29,697	5,700 Added 29.84%	24,800 $96,000
Q4 2019 Feb 12, 2020	SELL	$3.67 - $5.7 $41,838 - $64,980	-11,400 Reduced 37.38%	19,100 $70,000
Q2 2019 Aug 20, 2019	BUY	$2.7 - $6.11 $82,350 - $186,355	30,500 New	30,500 $117,000
Q4 2018 Feb 14, 2019	SELL	$1.92 - $3.62 $23,424 - $44,164	-12,200 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.81 - $3.78 $34,282 - $46,116	12,200 New	12,200 $46,000
Q1 2018 May 15, 2018	SELL	$2.39 - $4.01 $36,089 - $60,551	-15,100 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.51 - $4.4 $37,901 - $66,440	15,100	15,100 $59,000

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

Black Rock Inc. New York, NY

18.7M
Shares

$385 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

8.04M
Shares

$166 Million
0.0% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

6.23M
Shares

$128 Million
2.3% of portfolio
State Street Corp Boston, MA

5.69M
Shares

$117 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

3.02M
Shares

$62.2 Million
0.01% of portfolio

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account